Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Called TICO, our strategy is focused on developing and selling pharmaceutical products in the Topical, Injectable, Complex and Ophthalmic markets.
Based in Buena, New Jersey, we have approximately 100 employees working at our 33,000 square-foot manufacturing and R&D complex. We are in the early stages of a significant expansion to our production facility that will include a sterile injectable manufacturing suite and an expanded footprint for the production of our topical products.
There are three pillars that shape our company. First, we are driven by impactful science. Second, we accept no middle ground when it comes to product quality. Finally, we believe in fostering a career of craftsmanship, where our people can become experts in their trade.
The spirit of our culture is to work hard, and be nice to people.

Company Growth (employees)
Vineland, US
Size (employees)
107 (est)
Teligent is headquartered in Vineland, US

Teligent Office Locations

Teligent has an office in Vineland
Vineland, US (HQ)
105 Lincoln Ave

Teligent Financials and Metrics

Teligent Financials

Teligent's revenue was reported to be $19.9 m in Q1, 2017

Revenue (Q1, 2017)

19.9 m

Gross profit (Q1, 2017)

10.9 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

831 k

EBIT (Q1, 2017)

3 m

Market capitalization (16-Oct-2017)

357.2 m

Closing share price (16-Oct-2017)


Cash (31-Mar-2017)

59.5 m
Teligent's current market capitalization is $357.2 m.
USDFY, 2016


66.9 m

Cost of goods sold

32.2 m

Gross profit

34.7 m

Gross profit Margin, %

USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


6.9 m6.7 m10.7 m8.9 m11.6 m15.7 m17.1 m16.2 m19.9 m

Cost of goods sold

4 m4 m5 m5.2 m5.5 m7.7 m7.6 m8.1 m9 m

Gross profit

2.9 m2.6 m5.6 m3.7 m6.1 m8 m9.6 m8 m10.9 m

Gross profit Margin, %

USDFY, 2015FY, 2016


87.2 m66 m

Accounts Receivable

14 m21.7 m


9 m12.7 m

Current Assets

116.8 m103.3 m
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


2.4 m23.2 m157 m150.2 m145.7 m87 m81.2 m74.6 m59.5 m

Accounts Receivable

4.1 m6.4 m16.3 m17.3 m10.9 m13.2 m15.5 m17.2 m25.2 m


2.7 m3.2 m3.7 m4.1 m5 m10.1 m11 m12.5 m14.3 m

Current Assets

9.9 m33.8 m178.4 m173.1 m163 m117.7 m110.6 m106.9 m101.9 m
USDFY, 2015FY, 2016

Net Income

6.7 m(12 m)

Accounts Receivable

1.3 m(7.7 m)


(3.6 m)(5 m)

Accounts Payable

(2.8 m)4.7 m
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

167 k(202 k)6.6 m9.4 m(2.9 m)(950 k)(2.9 m)(2.7 m)831 k

Accounts Receivable

17.3 m10.9 m13.2 m15.5 m17.2 m25.2 m


4.1 m5 m10.1 m11 m12.5 m14.3 m

Accounts Payable

2.6 m3 m4.4 m4 m3.8 m8.1 m
USDY, 2017


185.9 k

Financial Leverage

3.3 x
Show all financial metrics

Teligent Market Value History

Traffic Overview of Teligent

Teligent Company Life and Culture

You may also be interested in